EMINENCE CAPITAL, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMINENCE CAPITAL, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$84,445,000
+153.3%
847,328
+192.0%
0.92%
+146.4%
Q4 2019$33,337,000
-11.5%
290,140
-2.9%
0.38%
-17.4%
Q3 2019$37,679,000
-64.4%
298,706
-66.1%
0.45%
-67.5%
Q2 2019$105,926,000
+987.4%
880,219
+690.5%
1.40%
+864.1%
Q1 2019$9,741,000111,3560.14%
Other shareholders
HAEMONETICS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders